![]()  | 
| 
		 A Case of Minimal Change Disease Treated Successfully with Mycophenolate Mofetil in a Patient with Systemic Lupus Erythematosus 
		Young Hoon Hong, Dae Young Yun, Yong Wook Jung, Myung Jin Oh, Hyun Je Kim, Choong Ki Lee 
		
		Korean J Intern Med. 2011;26(4):470-473.   Published online 2011 Nov 28		    DOI: https://doi.org/10.3904/kjim.2011.26.4.470
			 
	
	 | 
| 
		 Citations to this article as recorded by  
		Prednisolone 
							   
							   Reactions Weekly.2019; 1757(1): 264.     CrossRef Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study 
							   W X Hu, Y H Chen, H Bao, Z Z Liu, S F Wang, H T Zhang, Z H Liu 
							   Lupus.2015; 24(10): 1067.     CrossRef Acute kidney injury associated with minimal change disease in systemic lupus erythematosus: a case report 
							   Xin Wei, Ying Wang, Luxia Tu, Hongping Wan, Qinkai Chen 
							   Journal of Medical Case Reports.2014;[Epub]     CrossRef Minimal Change Disease in Systemic Lupus: Another Renal Manifestation of Lupus? 
							   Ki Heon Nam, Yoon Jin Cha, Young Eun Kwon, Yung Ly Kim, Kyoung Sook Park, Seong Yeong An, Beom Jin Lim, Hyeon Joo Jeong, Hyung Jung Oh, Tae-Hyun Yoo, Shin-Wook Kang, Kyu Hun Choi, Seung Hyeok Han 
							   The Ewha Medical Journal.2013; 36(2): 139.     CrossRef Reversible Minimal Change Nephrotic Syndrome and Glomerular IgA Deposition Associated with Nonparenteral Heroin Abuse: A Case Report 
							   Kenan Turgutalp, Ahmet Kiykim, Umit Karabulut, Didar Gursoy, Iclal Gurses 
							   Medical Principles and Practice.2012; 21(5): 492.     CrossRef 
	 |